NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-173-2015-0-PCT-02 Module For Freezing And Storage Of Frozen Tissue PCT PCT PCT/US2017/054531 Expired
NHLBI E-207-2016-0-PCT-02 METHOD FOR FUNCTIONALIZING CARBON NANOPARTICLES AND COMPOSITIONS PCT PCT PCT/US2017/054351 Expired
NHGRI E-090-2015-0-US-04 TAGGED FORM OF MUT ENZYME, GENETIC CONSTRUCTS INCORPORATING IT, AND ITS USE IN GENE THEREAPY US National Stage 15/563,379 Abandoned
NCI E-173-2015-0-EP-08 Module For Freezing And Storage Of Frozen Tissue EP DIV 22169969.7 Pending
NCI E-289-2011-0-MX-19 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF MX DIV MX/a/2017/012601 Pending
NIAID E-065-2018-0-EP-06 COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF EP National Stage 16847381.7 Issued
NCI E-176-2014-0-HK-14 Anti-Human Papillomavirus 16 E7 T Cell Receptors HK EP 17109823.5 Issued
NCI E-062-2019-3-HK-09 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide HK EP 62020002296.5 Issued
NIAID E-065-2018-0-JP-04 COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF JP National Stage 2017551585 Pending
NCI E-062-2019-3-PCT-01 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide PCT PCT COMB PCT/US2017/053766 Expired
NCI E-062-2019-3-CA-03 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide CA National Stage 3038500 Abandoned
NIAID E-065-2018-0-US-03 COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF US National Stage 15/561,622 Pending
NIAID E-065-2018-0-AU-07 COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF AU National Stage 2016323769 Issued
NCI E-025-2015-0-US-03 ANTI-CD133 MONOCLONAL ANTIBODIES AND RELATED COMPOSITIONS AND
METHODS 		US National Stage 15/561,403 10711068 Issued PDF
NCI E-086-2015-0-US-04 BISPECIFIC MULTIVALENT FUSION PROTEINS US National Stage 15/561,268 10472412 Issued PDF
NIAID E-239-2014-0-KR-04 MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE KR National Stage 10-2017-7027105 Abandoned
NIAID E-297-2016-2-PCT-01 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES PCT PCT COMB PCT/US2017/053047 Expired
NIAID E-297-2016-2-IN-04 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES IN National Stage 201917015489 Pending
NCI E-258-2016-0-EP-05 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE EP National Stage 17778069.9 Issued
NCI E-162-2014-0-HK-07 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE HK CN 17109560.2 Issued
NCI E-258-2016-0-JP-06 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE JP National Stage 2019-537030 Issued
NIAID E-089-2002-1-US-51 Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 US DIV 15/710,672 10837003 Expired PDF
NCI E-258-2016-0-PCT-02 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE PCT PCT PCT/US2017/052437 Expired
NCI E-258-2016-0-JP-08 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE JP DIV 2021-3261 Abandoned
NCI E-258-2016-0-AU-03 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE AU National Stage 2017332161 Pending
NCI E-258-2016-0-CA-04 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE CA National Stage 3037518 Pending
NCI E-258-2016-0-FR-01 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE FR EP 17778069.9 Pending
NCI E-258-2016-0-DE-01 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE DE EP 17778069.9 Pending
NCI E-258-2016-0-GB-01 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE GB EP 17778069.9 Pending
NCI E-106-2015-0-US-03 DUAL SPECIFIC ANTI-CD22-ANTI-CD19 CHIMERIC ANTIGEN RECEPTORS US National Stage 15/559,485 10738116 Issued PDF
NIAID E-131-2015-2-US-07 NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE US National Stage 15/559,791 10562960 Issued PDF
NCI E-184-2009-0-KR-20 COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS KR DIV 10-2017-7026393 Issued
NCI E-255-2012-0-US-04 Reversible Regulation Of Intein Activity Through Engineered New Zinc Binding Domain US DIV 15/707,588 10323235 Issued PDF
NCI E-280-2016-0-PCT-02 METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME PCT PCT PCT/US2017/051981 Expired
NCI E-280-2016-0-CA-03 METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME CA National Stage 3037882 Pending
NIDCR E-036-2010-1-EP-05 Compositions and Methods For Screening For Lyme Disease EP DIV 17191338.7 Issued
NCI E-106-2014-0-SG-17 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA SG DIV 10201707608Q Pending
NIAID E-233-2015-0-US-06 Intestinal Filarial Antigens For The Development Of Filaria Vaccines US National Stage 15/558,336 10441642 Issued PDF
NIAID E-233-2015-0-CA-04 Intestinal Filarial Antigens For The Development Of Filaria Vaccines CA National Stage 2979840 Abandoned
NIAID E-251-2016-0-GB-07 METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE GB EP 17784438.8 Issued
NIAID E-251-2016-0-DE-05 METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE DE EP 17784438.8 Issued
NIAID E-251-2016-0-FR-06 METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE FR EP 17784438.8 Issued
NIAID E-251-2016-0-EP-03 METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE EP National Stage 17784438.8 Issued
NCI E-269-2010-0-IL-12 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE IL DIV 254469 Issued
NIAID E-251-2016-0-PCT-02 METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE PCT PCT PCT/US2017/051413 Expired
NHGRI E-217-2007-0-US-15 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT US CON 15/702,529 10335426 Issued PDF
NCI E-039-2011-0-US-12 CHIMERIC RABBIT/HUMAN ROR1 ANTIBODIES US DIV 15/700,457 Abandoned
NEI E-050-2015-0-JP-07 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa JP National Stage 2017-547425 Issued
NIAID E-064-2015-2-US-05 MYELIN OLIGODENDROCYTE GLYCOPROTEIN, MYELIN BASIC PROTEIN, AND PROTEOLIPID PROTEIN COMPOSITIONS AND METHODS OF USE US National Stage 15/556,738 10759838 Issued PDF
NEI E-050-2015-0-US-08 RP2 AND RPGR VECTORS FOR TREATING X-LINKED RETINITIS PIGMENTOSA US National Stage 15/556,746 10646588 Issued PDF